These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes. Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868 [TBL] [Abstract][Full Text] [Related]
3. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease. Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of adult patients with congenital heart disease and an implantable cardioverter defibrillator. Coutinho Cruz M; Viveiros Monteiro A; Portugal G; Laranjo S; Lousinha A; Valente B; Osório P; Silva Cunha P; de Sousa L; Oliveira JA; Agapito A; Martins Oliveira M; Pinto F; Cruz Ferreira R Congenit Heart Dis; 2019 Jul; 14(4):525-533. PubMed ID: 30889316 [TBL] [Abstract][Full Text] [Related]
5. Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks? Krause U; Müller MJ; Wilberg Y; Pietzka M; Backhoff D; Ruschewski W; Paul T Europace; 2019 Jan; 21(1):106-113. PubMed ID: 30339209 [TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. Stefanelli CB; Bradley DJ; Leroy S; Dick M; Serwer GA; Fischbach PS J Interv Card Electrophysiol; 2002 Jul; 6(3):235-44. PubMed ID: 12154326 [TBL] [Abstract][Full Text] [Related]
7. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD). Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514 [TBL] [Abstract][Full Text] [Related]
8. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies. Garnreiter JM; Pilcher TA; Etheridge SP; Saarel EV Heart Rhythm; 2015 May; 12(5):937-42. PubMed ID: 25620047 [TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases. Benítez Ramos DB; Cabrera Ortega M; Castro Hevia J; Dorantes Sánchez M; Alemán Fernández AA; Castañeda Chirino O; Cruz Cardentey M; Martínez López F; Falcón Rodríguez R Pediatr Cardiol; 2017 Dec; 38(8):1663-1671. PubMed ID: 28871362 [TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands. Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697 [TBL] [Abstract][Full Text] [Related]